Your browser doesn't support javascript.
loading
Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells.
Okuno, Daisuke; Sugiura, Yuki; Sakamoto, Noriho; Tagod, Mohammed S O; Iwasaki, Masashi; Noda, Shuto; Tamura, Akihiro; Senju, Hiroaki; Umeyama, Yasuhiro; Yamaguchi, Hiroyuki; Suematsu, Makoto; Morita, Craig T; Tanaka, Yoshimasa; Mukae, Hiroshi.
Afiliación
  • Okuno D; Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
  • Sugiura Y; Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan.
  • Sakamoto N; Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
  • Tagod MSO; Center for Medical Innovation, Nagasaki University, Nagasaki, Japan.
  • Iwasaki M; Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Noda S; Center for Medical Innovation, Nagasaki University, Nagasaki, Japan.
  • Tamura A; Center for Medical Innovation, Nagasaki University, Nagasaki, Japan.
  • Senju H; Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
  • Umeyama Y; Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
  • Yamaguchi H; Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
  • Suematsu M; Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan.
  • Morita CT; Department of Internal Medicine and the Interdisciplinary Graduate Program in Immunology, University of Iowa Carver College of Medicine, Veterans Affairs Health Care System, Iowa City, IA, United States.
  • Tanaka Y; Center for Medical Innovation, Nagasaki University, Nagasaki, Japan.
  • Mukae H; Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Front Immunol ; 11: 1405, 2020.
Article en En | MEDLINE | ID: mdl-32793196
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Activación de Linfocitos / Linfocitos T / Citotoxicidad Inmunológica / Difosfonatos / Inmunoterapia Límite: Humans Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Activación de Linfocitos / Linfocitos T / Citotoxicidad Inmunológica / Difosfonatos / Inmunoterapia Límite: Humans Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza